Bridgeway Capital Management, LLC Savara Inc Transaction History

Bridgeway Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$2.97 - $3.88 $1.09 Million - $1.42 Million	-366,393 Reduced 94.73%	20,400 $77,000
Q4 2021 Feb 14, 2022	BUY	$1.04 - $1.34 $364,000 - $469,000	350,000 Added 951.27%	386,793 $480,000
Q3 2021 Nov 15, 2021	SELL	$1.18 - $1.64 $116,356 - $161,715	-98,607 Reduced 72.83%	36,793 $51,000
Q2 2021 Aug 16, 2021	SELL	$1.51 - $2.29 $8,456 - $12,824	-5,600 Reduced 3.97%	135,400 $230,000
Q1 2021 May 17, 2021	SELL	$1.17 - $2.33 $59,787 - $119,063	-51,100 Reduced 26.6%	141,000 $293,000
Q4 2020 Feb 16, 2021	SELL	$1.0 - $1.47 $52,400 - $77,028	-52,400 Reduced 21.43%	192,100 $221,000
Q3 2020 Nov 16, 2020	SELL	$1.09 - $2.21 $142,681 - $289,289	-130,900 Reduced 34.87%	244,500 $267,000
Q2 2020 Aug 14, 2020	BUY	$1.8 - $3.05 $351,000 - $594,750	195,000 Added 108.09%	375,400 $935,000
Q1 2020 May 15, 2020	SELL	$1.91 - $4.08 $35,908 - $76,704	-18,800 Reduced 9.44%	180,400 $382,000
Q4 2019 Feb 14, 2020	BUY	$0.71 - $4.91 $31,382 - $217,022	44,200 Added 28.52%	199,200 $892,000
Q3 2019 Nov 14, 2019	BUY	$2.16 - $3.2 $248,400 - $368,000	115,000 Added 287.5%	155,000 $411,000
Q2 2018 Aug 14, 2018	BUY	$8.55 - $13.76 $342,000 - $550,400	40,000 New	40,000 $453,000

128

158M

67.6K

29.4K

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $365M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.